BNR Stock Analysis: Buy, Sell, or Hold?
BNR - Burning Rock Biotech Limited American Depositary Shares
$10.69
-0.61 (-5.40%)
▼
5d:
+3.48%
30d:
+28.33%
90d:
-32.53%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jun 05, 2026
0d
Get Alerted When BNR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BNR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BNR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BNR is currently trading at $10.69, which is considered extended relative to its 30-day fair value range of $7.71 to $10.32.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $8.06, while resistance sits at $12.89. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: BNR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.03. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BNR is in a strong downtrend. Immediate support is located at $8.06, while resistance sits at $12.89. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: BNR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $4.03. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.71 -
$10.32
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BEARISH: Trading 64.3% above Wall St target ($4.03)
Trading Range Analysis
30-Day Trading Range
$7.71 -
$10.32
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$8.06
Resistance Level
$12.89
Current Trend
Strong Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Wall Street Target
$4.03
(-64.3%)
Revenue Growth (YoY)
-18.9%
Profit Margin
-11.5%
Share & Embed Analysis
Last updated: July 13, 2026 3:35 PM ET
Data refreshes hourly during market hours. Next update: 4:35 PM
Data refreshes hourly during market hours. Next update: 4:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yusheng Han
BUY
314870 shares
2026-03-31
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 67 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 60 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 54 HOLD |
